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ABSTRACT The structure, assembly, and function of the bacterial flagellum involves about 60 different proteins, many of which
are selectively secreted via a specific type III secretion system (T3SS) (J. Frye et al., J. Bacteriol. 188:2233–2243, 2006). The T3SS is
reported to secrete proteins at rates of up to 10,000 amino acid residues per second. In this work, we showed that the flagellar
T3SS of Salmonella enterica serovar Typhimurium could be manipulated to export recombinant nonflagellar proteins through
the flagellum and into the surrounding medium.We translationally fused various neuroactive peptides and proteins from snails,
spiders, snakes, sea anemone, and bacteria to the flagellar secretion substrate FlgM.We found that all tested peptides of various
sizes were secreted via the bacterial flagellar T3SS. We subsequently purified the recombinant-conotoxin SIIIA (rSIIIA) from
Conus striatus by affinity chromatography and confirmed that T3SS-derived rSIIIA inhibited mammalian voltage-gated sodium
channel NaV1.2 comparably to chemically synthesized SIIIA.
IMPORTANCE Manipulation of the flagellar secretion system bypasses the problems of inclusion body formation and cellular deg-
radation that occur during conventional recombinant protein expression. This work serves as a proof of principle for the use of
engineered bacterial cells for rapid purification of recombinant neuroactive peptides and proteins by exploiting secretion via the
well-characterized flagellar type III secretion system.
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Although large strides have been made in the recombinant ex-pression of proteins, the efficient expression of certain classes
of proteins remains a challenge. These include the small, highly
stable pharmacologically active polypeptides with a high density
of disulfide cross links. A major group within this general class
includes the polypeptides present in animal venoms. Although
several different phylogenetic lineages have evolved venoms inde-
pendently, all polypeptides found have convergently evolved a
common set of properties that allow them to be exceptionally
stable upon injection into another organism. These polypeptides
are of increasing interest, because many of them have novel phar-
macological activity and therefore serve as useful ligands in basic
research or have direct diagnostic and therapeutic applications.
Furthermore, in contrast to some neuroactive toxins, such as te-
trodotoxin or saxitoxin, conopeptides do not pass the gut, thus
minimizing potential toxicity. Conopeptides also have a medical
advantage in that they are similar to endogenous peptide ligands
(enkephalins) that lack addictive properties compared to other
receptor-binding ligands that are addictive, such as heroin or
morphine. One of these peptides, MVIIA, a 25-amino-acid pep-
tide with three disulfide bonds, has become an approved drug for
intractable pain (1–3).
When recombinant expression of small disulfide-rich poly-
peptides is attempted, the yields are generally low. A fundamental
problem is that when expression levels are high, the resulting high
concentrations of polypeptide in the cell lead to the formation of
intermolecular aggregates, and recombinant polypeptides are
found mostly in inclusion bodies. The ability to recover the poly-
peptide from an inclusion body in a biologically active form is not
predictable and requires additional steps that vary depending on
the polypeptide expressed.
In this work, we initiated a new approach that uses an expres-
sion system that should, in theory, bypass the inclusion body
problem of recombinant small peptide expression. It exploits the
flagellar secretion system of Salmonella enterica serovar Typhimu-
rium (reviewed in references 4 and 5) that has been shown to
export nonflagellar proteins if fused to flagellar secretion signals,
e.g., hook protein FlgE (6) or flagellin FliC (7). The flagellar secre-
tion system is a member of a family of bacterial type III secretion
systems that selectively secrete proteins from the cytoplasm to the
external medium. Almost all type III secretion systems character-
ized thus far are either required for the secretion of virulence de-
terminants for a number of plant and animal pathogens or for the
secretion of proteins required for the structure and function of the
bacterial flagellum. About 60 genes are involved in assembly and
regulation of the bacterial flagellum (8). The overall structure is
composed of an external helical filament, extending many body
lengths from the cell surface, attached to a rotarymotor embedded
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within the cell wall and membranes. For Salmonella, a chemosen-
sory system controls the clockwise and counterclockwise direction
of flagellar rotation, which allows the bacterium tomigrate toward
attractants, such as nutrients, or away from repellents that are
harmful to the bacterium.
The specificity for flagellar substrate secretion is primarily de-
termined by an N-terminal peptide secretion signal that has a
disordered structure.Many secretion substrates also require a spe-
cific secretion chaperone to facilitate secretion. One flagellar se-
cretion substrate, FlgM, is a regulatory protein that couples flagel-
lar assembly to gene expression (9–12). 28, a transcription factor
specific for flagellar promoters, directs transcription of genes spe-
cifically needed after completion of the flagellar hook-basal body
structure (HBB) and thereby induces expression of the filament
and chemosensory genes. FlgM binds 28 and prevents its associ-
ation with RNA polymerase. Completion of the flagellar hook
results in a change in substrate specificity of the flagellar secretion
apparatus, switching from secretion of proteins required for
hook-basal body assembly to late substrate secretion of proteins
needed in filament assembly. FlgM itself is a late secretion sub-
strate and its secretion releases 28, enabling it to transcribe the
filament and chemosensory genes only upon completion of the
HBB (11, 13). At the same time, the28 transcription factor acts as
the secretion chaperone that facilitates the secretion of its inhibi-
tor, FlgM (14).
In this work, we utilized the flagellar FlgM protein as a vector
for the secretion of the small, highly stable pharmacologically ac-
tive polypeptides that contain a high density of cysteine residues,
which formdisulfide cross-links in themature product. As a proof
of principle, we engineered a bacterial secretion system for the
recombinant expression of -conotoxin SIIIA in Salmonella Ty-
phimurium.Using the flagellar type III secretion (T3S) apparatus,
the recombinant conopeptidewas selectively secreted into the cul-
ture medium (Fig. 1).
RESULTS AND DISCUSSION
Conopeptides are synthesized in the venom duct of marine cone
snails and target ion channels, including voltage-gated sodium
channels (VGSCs) (15). SIIIA is a -conotoxin from Conus stria-
tus that inhibits tetrodotoxin (TTX)-resistant VGSCs in frog (16)
and TTX-sensitive VGSCs in rodents (17). The -conotoxin
SIIIA binds to site 1 of the -subunit of VGSCs (18–20) and
thereby occludes the channel pore and blocks sodium conduc-
tance. Under physiological conditions, two forms of SIIIA exist,
a precursor form and a mature peptide, which has been modified
by processing the C-terminal glycine-arginine residues to an
amino group and changing the N-terminal glutamine residue to
pyroglutamate. In this work, we recombinantly expressed two
forms of SIIIA, the precursor peptide and a peptide that most
closely resembles the physiological mature form (N-terminal glu-
tamate instead of pyroglutamate). In mammalian preparations,
-SIIIA effectively blocks neuronal sodium channels, such as
NaV1.2 and NaV1.6, and the skeletal muscle subtype NaV1.4 (17).
Because SIIIA targets VGSCs and has potent analgesic activity in
mice (21), it is a promising peptide for medical research and drug
discovery (22). The fundamental advantage in developing our
T3SS bacterial expression system is that after translation the poly-
peptides translocate through a narrow secretion channel in the
flagellar structure and thereby bypass the problem of aggregation
in inclusion bodies. Polypeptide secretion should prevent inter-
molecular aggregation in the cytoplasm. Intramolecular disulfide
bonds should form as the polypeptide chain exits the reductive
environment of the bacterial cytoplasm and enters an oxidizing
extracellular environment.
We focused on assessing how efficiently different constructs
serve as type III secretion substrates. The SIIIA pretoxin (-
SIIIApre in Table 1 and henceforth referred to as rSIIIA) is a small
22-amino-acid peptide which was fused to FlgM with an
N-terminal TEV cleavage site in front of SIIIA. In order to ensure
proper secretion and to diminish the possibility of interference
with the structural secretion signal of FlgM, three different con-
structs were designed with a polyhistidine tag at different posi-
tions. All constructs were chromosomally expressed from the
arabinose-inducible promoter ParaBAD. Figure 1b shows the secre-
tion profile of all three constructs. Construct 3 (FlgM-H6-TEV-S
IIIA) displayed the most prominent secretion product; construct
2 (FlgM-TEV-SIIIA-H6) exhibited the lowest secretion level. This
secretion ranking was consistent in all backgrounds tested, some
of which carried amutation (fliA*, with the asterisk indicating the
mutation [H14D]) in the 28 structural gene fliA that enhances
stability of this FlgM secretion chaperone protein (9). As expected,
FlgM levels were very low in a strain unable to form a flagellar
structure (fliF strain) compared to those in a wild-type strain.
The flagellum-specific transcription factor 28 acts as a chap-
erone to facilitate FlgM secretion. As shown in Fig. 1c, 28 H14D,
with its enhanced stability (10), increased levels of intracellular
and secreted FlgM-SIIIA. 28 H41D also increases FlgM stability
(14). This is the likely cause of the increased levels of FlgM-SIIIA
in the fliA* background (Fig. 1c, lanes 2 and 3). We also tested the
effect of removing the late flagellar secretion substrates (and po-
tential secretion competitors) FliC and FliD (fliCD). The fliC
and fliD genes are divergently transcribed. However, the fliD gene
is in an operon with fliT, which encodes the FliT inhibitor of all
flagellar gene expression. Thus, the fliCD deletion results in re-
moval of secretion competitors for FlgM in addition to increasing
the number of flagellar basal structures (11). The net effect was
increased production and secretion of both FlgM and FlgM-SIIIA
from the cell (Fig. 1c, lanes 2 and 4).
As FlgM-H6-TEV-SIIIA showed the highest level of secretion,
this construct was used for further purification experiments. The
SIIIA fusionwas expressed froman arabinose-inducible promoter
to allow synchronization of the high level of expression with com-
pletion of the flagellar secretion systems. Secreted FlgM-H6-TEV-
SIIIA was separated from the bacterial cell culture by centrifuga-
tion and was obtained from the supernatant under native
conditions by nickel-affinity chromatography. As shown in
Fig. 2a, FlgM-H6-TEV-SIIIA efficiently bound to the Ni-IDA res-
ins andwas elutedwith imidazole-containing elution buffer. After
concentration of the eluted fraction, rSIIIA was cleaved from the
FlgM-H6-TEV secretion signal using TEV protease. Western blot
analysis and Coomassie staining demonstrated that TEV cleavage
was complete after 3 h at room temperature (data not shown).
As with all cysteine-rich peptides, the formation of the native
disulfide bonds is a crucial process in generating biologically ac-
tive SIIIA. However, the optimal buffer conditions of the TEV
protease require 1 mM dithiothreitol (DTT). This redox agent
provides reducing power for the TEV protease but at the same
time should reduce S-S bonds in the peptide of interest. For this
reason, we decided to refold rSIIIA prior to electrophysiological
analysis. Refolding was carried out in a redox buffer of oxidized
Singer et al.
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FIG 1 Engineering the flagellar type III secretion system for the secretion of SIIIA conotoxins. (a) Model: An FlgM-SIIIA translational fusion is a secretion
substrate of the bacterial T3SS. The fusion construct is secreted via the flagellum-specific T3SS through the flagellar channel into the culturemedium via flagellar
structures that are competent for FlgM secretion. Expression of FlgM-SIIIA is induced upon addition of arabinose and is independent of flagellar class I and II
gene expression. During HBB assembly, FlgM remains inside the cytosol and acts as an anti-28 factor preventing transcription of class III genes, e.g., genes
encoding the flagellin subunit FliC or the stator proteins MotA andMotB. The HBB structure is completed within 30 min (39), which coincides with a substrate
specificity switch within the flagellar secretion apparatus (indicated by an orange asterisk in the figure) from early to late substrate secretion. This results in
secretion of FlgM and substrates needed during the final phase of flagellum assembly. OM, outer membrane; PG, peptidoglycan layer; IM, inner membrane. (b)
Expression and secretion of the FlgM-SIIIA fusion protein. Secreted FlgM-SIIIAwas precipitated using TCA, and immunoblots with antibodies against FlgM are
shown for cellular and supernatant fractions. Protein bands of native FlgM (o) and FlgM-SIIIA (‘) fusions aremarked next to the blot. Constructs 1 to 3 (labeled
c1 to c3) represent the following protein fusions: c1H6-FlgM-TEV-SIIIA, c2FlgM-TEV-SIIIA-H6, c3FlgM-H6-TEV-SIIIA. Secretion efficiencies of three
FlgM-SIIIA constructs varying in their position of the polyhistidine tag were tested. Secretion levels are shown for TH437 (wt, lane 1), TH4885 (fliF, lane 2),
TH5139 (flgM, lane 3), TH10874 (Para::flgM, lane 4), TH15705 (fliA* Para::c1, lane 5), TH15706 (fliA* Para::c2, lane 6), and TH15707 (fliA* Para::c3, lane 7).
Wild-type FlgM bands in lanes 5 to 7 were visible upon extended exposure. (c) FlgM-H6-TEV-SIIIA was expressed from the arabinose promoter, and secretion
was compared in fliAwt (lane 2), fliA* (H14D, lane 3), andfliCD (lane 4) backgrounds. Secretion of wild-type FlgM expressed from its native promoter is shown
in lane 1 (TH437, labeled wt).
Recombinant Peptide Secretion via Bacterial Flagella
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and reduced glutathione, allowing thiol-disulfide exchange reac-
tions under conditions that are known to favor formation of the
native disulfide bonds (16).
Tests of the rSIIIA precursor formonXenopus oocytes express-
ing rat NaV1.2 demonstrated that its functional activity was simi-
lar to that of chemically synthesized SIIIA. Sodium currents in
response to depolarization were recorded as described in Materi-
als and Methods. Figure 2b presents the results from a represen-
tative experiment in which rSIIIA blocked NaV1.2 conductance
(compare the peak current of the oocyte before [gray trace] and
after [black trace] rSIIIA exposure). The kinetics of the onset of
block following exposure to 10 M rSIIIA and the recovery from
block following itswashoutwere assessed as described inMaterials
and Methods. The observed rate constant for the onset of block
(kobs) and the rate constant for recovery from block (koff) were,
respectively, 0.17  0.04 min1 and 0.0043  0.0004 min1
(mean standard deviation [SD]; n 3 oocytes). The koff value is
close to that observedwith chemically synthesized SIIIA; however,
the kobs value is about 6-fold lower than that observed with chem-
ically synthesized SIIIA (17). The difference in kobs is thought to be
due to the disparity in the sequences of the two peptides (N-
terminal glycine carryover after TEV cleavage and lacking post-
translational modifications), and experiments are under way to
test this assumption.
In addition to the secretion of SIIIA pretoxin, several other
peptides from various organisms, such as spider (GsMTx4), scor-
pion (chlorotoxin), snake (calciseptine), snails (-MVIIA,
-GVIA, contulakin-G, -Vc1.1, conantokin-G, mature SIIIA),
and sea anemone (Shk) were tested for recombinant expression
and subsequent secretion in a complementary approach (see Ta-
ble 1 for a detailed list). Although there were differences in cellular
levels and secretion efficiencies, the results shown in Fig. 2c dem-
onstrate that all tested peptides were secreted into the culture su-
pernatant.We also tested the secretion of the unstable 190-amino-
acid-long catalytic subunit of diphtheria toxin fused to FlgM
(Fig. 2d). Notably, the proteolytic degradation that was observed
within the cytosolic fraction did not occur once the protein was
secreted from the cell.
For further optimization of the Salmonella secretion strain, a
nonmotile polyhookmutant was constructed that had the follow-
ing characteristics. It lacked the flagellum-related SPI-1 (prgH-
hilA) virulence system, as well as all class 3 flagellar genes (flgKL,
fljB-T, flgMN, aer-mcpC, PmotA, motA-cheZ, mcpA,
mcpB, tsr) that could diminish or interfere with flagellar type
III secretion of the toxin fusion of interest. In addition, the strain
harbored a mutation in the flhD promoter (P*flhD) and was de-
leted for negative regulators of the flagellar master regulator
FlhD4C2 (lrhA,ydiV,ecnR). LrhA acts as a negative regulator
of flhDC transcription by directly binding to the promoter region
of the master regulator (23). The EAL domain protein YdiV post-
translationally regulates the activity of the FlhD4C2 protein by
targeting the complex for ClpXP-dependent degradation and
thereby negatively influences FlhDC-dependent flagellar class 2
promoter activity (24, 40). Transposon insertions in those nega-
tive regulators of FlhDC have been shown to increase flagellar
gene expression (25, 26).
As shown by fluorescent labeling of the flagellar hook struc-
tures in Fig. 3a, these mutations resulted in a roughly 2-fold in-
crease of flagellar secretion structures per cell compared to wild-
type cells, which in turn led to a substantial increase in the
secretion rate of flagellar proteins. Secretion rates of FliK and
FlgM-SIIIA (construct 3) were roughly 2-fold higher in the poly-
hook background than in the wild-type and fliA* backgrounds
(Fig. 3b).
The major advantage of this system is the workflow. After in-
duction with arabinose, the bacterial cells express recombinant
polypeptides and subsequently secrete the toxin into themedium.
Contrary to the purification of neuropeptide by traditional meth-
ods (27), this makes it unnecessary to lyse cells in order to purify
peptides. Instead, recombinant SIIIA was selectively secreted via
the flagellar T3SS and it accumulated in the culture supernatant.
After several hours of production, cells were removed by simple
centrifugation and filtration. Other important aspects of this sys-
tem are type III secretion chaperones that facilitate secretion or
increase the stability of the secretion substrates. Type III secretion
substrates are usually secreted in an unfolded or partially folded
TABLE 1 Peptides used in this study
Peptide name Organism Species Peptide size (aa) Amino acid sequence (without modifications)
-MVIIA Cone snail Conus magus 25 CKGKGAKCSRLMYDCCTGSCRSGKC
-GVIA Cone snail Conus geographus 27 CKSPGSSCSPTSYNCCRSCNPYTKRCY
Contulakin-G Cone snail Conus geographus 16 ESEEGGSNATKKPYIL
-Vc1.1 Cone snail Conus victoriae 16 GCCSDPRCNYDHPEIC
Conantokin-G Cone snail Conus geographus 17 GEEELQENQELIREKSN
-SIIIAmat Cone snail Conus striatus 20 ENCCNGGCSSKWCRDHARCC
-SIIIApre Cone snail Conus striatus 22 QNCCNGGCSSKWCRDHARCCGR
Shk Sea anemone Stichodactyla helianthus 35 RSCIDTIPKSRCTAFQCKHSMKYRLSFCRKTCGTC
Chlorotoxin Scorpion Leiurus quinquestriatus 36 MCMPCFTTDHQMARKCDDCCGGKGRGKCYGPQCLCR
GsMTx4 Spider Grammostola spatulata 35 GCLEFWWKCNPNDDKCCRPKLKCSKLFKLCNFSSG
Calciseptine Snake Dendroaspis polylepis polylepis 60 RICYIHKASLPRATKTCVENTCYKM
FIRTQREYISERGCGCPTAMWPYQTECCKGDRCNK
DTA Y65A Bacterium Corynebacterium diphtheriae 190 GADDVVDSSKSFVMENFSSYHGTKPGYVDSIQK
GIQKPKSGTQGNYDDDWKGFYSTDNKYDAAGASV
DNENPLSGKAGGVVKVTYPGLTKVLALKVDNAE
TIKKELGLSLTEPLMEQVGTEEFIKR
FGDGASRVVLSLPFAEGSSSVEYINN
WEQAKALSVELEINFETRGKRGQDAMYEYMAQACAGNR
Singer et al.
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state, which is often achieved by interaction of the chaperones
with the secondary structure of the secreted protein. Since SIIIA
was fused to FlgM, a type III secretion substrate, it was likely pro-
tected from premature folding by interaction with FliA (28), the
cognate type III secretion chaperone of FlgM (14). In the past,
shorter fragments of FliC containing only the presumed type III
secretion signal were used as a secretion shuttle (7). For our re-
combinant expression, we intentionally used full-length FlgM,
which increased secretion efficiency due to the presence of its FliA
chaperone-binding site.
In summary, this system provides an easy-to-use method
for complicated peptide purification—a task that goes beyond
yield and solubility of peptides and requires the peptides and
proteins to be accessible in a correctly folded and active state.
As shown here, this technique could be of use for the diverse
array of different bioactive small peptides that is especially ap-
parent within the venom of cone snails. More than 500 species
of fish-, mollusk-, and worm-hunting cone snails have evolved,
and every Conus species appears to have a repertoire of around
100 different venom components, mostly small, disulfide-rich
peptides that rapidly affect the prey organism at multiple tar-
gets. Each neuroactive peptide of the venom is highly specific
for an individual channel isoform, and it is estimated that
50,000 conopeptides exist, but less than 0.1% have been char-
acterized pharmacologically (22, 28). To make use of this po-
tential, it is necessary to isolate and characterize the target and
mode of action of single venom components. The identifica-
tion of neuroactive ligands has a potential to make a significant
contribution to understanding the molecular basis of electrical
signaling in the nervous system of mammals. Additionally, in-
dividual peptides come into consideration as potential phar-
maceutical agents—as analgesics and as drugs for the treatment
of various diseases such as epilepsy, autoimmune diseases, or
even spinal cord injuries.
FIG 2 Purification and electrophysiology of recombinant conotoxin SIIIA and secretion of toxins from various organisms via the flagellar T3SS. (a) The
supernatant of a strain expressing and secreting recombinant SIIIA fused to FlgM (TH15707 fliA* [H14D]araBAD1036::flgM-H6-TEV-SIIIA) was filtered and
bound to an Ni2-IDA column as described in Materials and Methods. The matrix was washed after binding (W1 to W3), and FlgM-SIIIA was eluted in three
steps with imidazole-containing elution buffer (E1 to E3). For Western blot detection, samples were TCA precipitated. Due to the increased FlgM-SIIIA
concentration in the elution fractions, only 1/10 of the volume was used for TCA precipitation of elution fractions 1 to 3. (b) Recombinant SIIIA blocks
voltage-gated sodium channelNaV1.2. AXenopus oocyte expressing ratNaV1.2was exposed to 10MrSIIIA, while sodium currents weremonitored as described
in Materials and Methods. Currents recorded before toxin exposure (control, gray trace) and following ~20-min exposure to 10 M rSIIIA (black trace). Each
trace represents the average of five responses. The difference of the peak values between the two traces corresponds to the inhibitory effect rSIIIA has on channel
NaV1.2. FlgM-H6-TEVwas translationally fused to six different peptides from cone snails and one peptide each from a sea anemone, scorpion, spider, and snake
(c), and FlgM-H6was fused toCorynebacteriumdiphtheriae (d) (see also Table 1 for a detailed list). Peptides were expressed in a Salmonella polyhook background
(see text for details). Secretion of diphtheria toxin fragment A from Salmonella strain TH16229 was tested using three independent biological replicates (labeled
1 to 3). Secretion of recombinant peptides was performed as described before.
Recombinant Peptide Secretion via Bacterial Flagella
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FIG 3 Effect of Salmonella polyhook background on secretion. (a) Immunostaining of the polyhook background TH16778 used for secretion of FlgM-H6-
TEV-toxin fusions. A three-fold repeat of a hemagglutinin epitope tag was inserted into the flagellar hook subunit to facilitate hook detection by fluorescent
microscopy. Red, membrane stained with FM-64; blue, DNA stained with Hoechst; green, flagellar hook-basal-body complexes (flgE::3HA) labeled with
antihemagglutinin antibodies coupled to Alexa Fluor 488. The scale bar is 5 m. (b) Secreted proteins were precipitated using TCA, and immunoblots with
antibodies against FlgMand FliK are shown for cellular and supernatant fractions. Protein bands of native FlgM (o) and FlgM-SIIIA fusions (‘) aremarked next
to the blot. Secretion levels were compared by measuring the densiometric intensity of the detected bands using ImageJ (37). Secretion values relative to the
secretion in a Para wild-type background (first lane) are displayed below the corresponding band.
Singer et al.
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MATERIALS AND METHODS
Bacterial strains and media. All bacterial strains used in this study are
listed in Table S1 in the supplemental material. The commonly used non-
pathogenic strain of Salmonella enterica serovar Typhimurium LT2 was
used for all experiments. LT2 harbors mutations in the ropS and mviA
genes that render it avirulent (29–31). The mviA gene encodes for the
regulator of a two-component system involved in Salmonella virulence.
The rpoS gene product (stationary-phase sigma transcription factor) is
required for the expression of multiple virulence factors. The two muta-
tions within the virulence pathway of Salmonella result in attenuation of
virulence. To further ensure nonpathogenicity of the used bacterial ex-
pression strains, most experiments were performed in a strain deleted for
major structural parts and the master regulator of the SPI-1 injectisome
virulence system (prgH-hilA).
Cells were cultured in Luria-Bertani (LB) medium and, when neces-
sary, supplemented with ampicillin (100 g/milliliter) or tetracycline
(15 g/milliliter). The generalized transducing phage of S. Typhimurium
P22 HT105/1 int-201 was used in all transductional crosses (32).
All work regarding Salmonella Typhimurium was performed with in-
stitutional approval, and in particular work with purified conotoxin SIIIA
was performed under select agent rules at the University of Utah.
Construction of chromosomally expressed flgM-toxin fusions.
SIIIA was amplified with a de novo fill-in PCR reaction using a long
primer, SIIIA_long_fw (CAGAACTGCTGCAACGGCGGCTGCAGCAG
CAAATGGTGCCGCGATCATGCGCGCTGCTGCGGCCGC), covering
all 66 bp encoding SIIIA (QNCCNGGCSSKWCRDHARCCGR). The
SIIIA sequence was designed according to the optimal codon usage of
Salmonella Typhimurium. The 66-bp sequence was duplexed with the
help of a short reverse primer (SIIIA_short_rv: GCGGCCGCAGCAGCG
CGCATG) initiating the fill-in from the 3= end of the template primer.
A cleavage site for the TEV protease (ENLYFQG) and a polyhistidine
tag [H6 encoded by (CATCAC)3, indicating a triple repeat of two codons
encoding the same 6 amino acids] were inserted during amplification of
flgM and SIIIA at various positions, resulting in three different construct
(named constructs 1 to 3).
Below, the construction procedure of construct 1 will be explained
exemplarily inmore detail, and construct 2 and construct 3 were designed
accordingly (see Table S2 in the supplemental material for primer se-
quences). The flgM gene was amplified from genomic DNA (TH2788)
using forward primer 1_HS1_flgM_fw and reverse primer
1_HS2_flgM_rv. The reverse primer encoded an 18-bp overhang that was
homologous to the 5= SIIIA sequence (see above). To increase the length
of the homologous region, SIIIA was amplified from the previous synthe-
sized template with primers 1_HS3_SIIIA_fw and 1_HS4_SIIIA_rv, add-
ing an additional 10-bp overlap with homology to the sequence of the
TEV protease cleavage site. The PCR products of FlgM and SIIIA were
purified and used in a subsequent fusion PCR as a template together with
forward primer 1_HS1_flgM_fw and reverse primer 1_HS4_SIIIA_rv.
Thismethod allows the fusion of twoPCRproducts that share a homology
of (in case of construct 1) 28 bp, resulting in one long flgM-SIIIA fusion
construct. All constructs contained a 5=-BamHI and a 3=-EcoRI restriction
site for cloning into pUC18, resulting in the subcloning vectors (pHS1
[pUC18 BamHI-His6-flgM-TEV-SIIIA-EcoRI], pHS2 [pUC18 BamHI-
flgM-TEV-SIIIA-His6-EcoRI], and pHS3 [pUC18 BamHI-flgM-His6-
TEV-SIIIA-EcoRI]).
All flgM-SIIIA fusions were amplified from the respective subcloning
vectors with primers having homologous regions for the native flgM locus
or the arabinose locus (araBAD). Chromosomal insertions were con-
structed using -Red-mediated recombination as described before (33).
The expression of SIIIA in Salmonella resulted in a recombinant pep-
tide that was lacking posttranslationalmodifications that are usually pres-
ent under physiological conditions. Those include a neutral N-terminal
pyroglutamate, C-terminal amidation, and cleavage of a two-residue frag-
ment named SIIIApre. However, according to functional studies on the
related -conotoxin GIIIA, the potency of SIIIA is thought to be deter-
mined by the lysine at position 11 (16, 34–36) and therefore should not be
affected by any N- and C-terminal sequence variations.
All other peptides from various organisms (snails, spiders, snakes, and
sea anemone) were constructed correspondingly, and their sequences are
listed in Table 1 and Table S2 in the supplemental material.
Fragment A of the diphtheria toxin (DTA Y65A) was amplified from
plasmid pTH794 with primers DTA-flgM_fw (ACTCGCTCATTCGCGA
GGCGCAGAGCTACTTACAGAGTAAAGGCAGCTCTCACCACC
ACC) and DTA-flgM_rv (TTCATCAACGCGCCCCCCATGGGACGCG
TTTTTAGA GGCATTAACGGTTACCTGCACAAG). DTA amplifica-
tion included a polyhistidine tag (H6) with a GSS linker before the His tag
and an SSGLVPR linker between the His tag and the first amino acid of
DTA. DTA was chromosomally inserted by -Red-mediated recombinat
ion. The insertion was carried out in a araBAD::flgM background.
DTA was targeted in front of the flgM stop codon, resulting in a translat
ional flgM-DTA fusion.
Recombinant expression and purification of SIIIA conotoxin.
Strains expressing SIIIA conotoxin fusions were picked from a fresh single
colony and grown in 10 ml LB overnight. The overnight cultures were
diluted 1:100 into 1 liter of fresh medium and grown for 6 h. If appropri-
ate, SIIIA expressionwas induced after the first 2 h by the addition of 0.2%
arabinose. Cells were pelleted by centrifugation (7,000 rpm), and the su-
pernatant containing FlgM-SIIIA was passed through a 0.22-m poly-
ethersulfone filter (Corning, NY), a low-protein-binding membrane for
removal of residual bacteria. For further purification, a gravity flow col-
umn (Bio-Rad) packed with 3 gNi-IDA resin (ProtinoNi-IDA;Machery-
Nagel) was used, and affinity-tagged proteins were eluted under native
conditions at pH 7.5 with a buffer containing 250 mM imidazole.
Secretion assay. Overnight cultures were diluted 1:100 in LB and
grown for 2 h at 37°C before inducing the expression of the respective
FlgM-toxin fusion by adding 0.2% l-arabinose. Cells were kept at 37°C for
an additional 4 h, while the fusion proteins were expressed. After a total of
6 h, the optical density at 600 nm (OD600) was determined for all strains.
Two-milliliter aliquots of the resulting cell culture were centrifuged
for 10 min at 4°C and 7,000 rpm to obtain, for each aliquot, a pellet and
supernatant. The supernatant was filtered through a low-protein-binding
filter with a 0.2-mpore size (Acrodisk syringe filter; Pall Life Sciences) to
remove the remaining cells. Alternatively, aliquots were centrifuged twice
at maximum speed to remove residual cells. Secreted proteins in the fil-
tered or twice-centrifuged supernatant were precipitated by the addition
of TCA (10% final concentration). The supernatant samples were resus-
pended in 2 SDS sample buffer (100 mM Tris [pH 6.8], 4% SDS, 10%
glycerol, 2% -mercaptoethanol, 25 mM EDTA, 0.04% bromophenol
blue) and adjusted to 20 OD600 units/l. The cellular pellet fraction was
suspended in 2 SDS sample buffer, whose volume was adjusted to yield
20 OD600 units/l.
SDS-PAGE and Western blotting. Expressed FlgM-toxin fusions of
whole-cell lysate and cultural supernatant were subjected to SDS poly-
acrylamide gel electrophoresis and analyzed by immunoblotting using
polyclonal anti-FlgM and polyclonal anti-FliK antibodies (rabbit) for de-
tection. Antigen-antibody complexes were visualized by chemilumines-
cent or infrared detection using the LI-COROdyssey imaging system. For
chemiluminescent development, secondary goat -rabbit antibodies
(Bio-Rad) conjugated with horseradish peroxidase (HRP) and an ECL
detection kit (Amersham Biosciences) were used. For infrared detection,
secondary anti-rabbit IRDye690 (LI-COR) was used. Densiometric mea-
surements of FlgM-SIIIA and FliK bands were performed using ImageJ
1.45s for Mac OS X (37).
TEV protease cleavage. SIIIA was cleaved off flagellar secretion sub-
strates using AcTEV protease (Invitrogen). A total of 450 unified atomic
mass units of TEV protease was added to 15 ml of the elution fraction,
which corresponds to the secreted proteins from a 750-ml culture. Cleav-
age was performed overnight at room temperature in elution buffer con-
taining 1 mM DTT and 0.5 mM EDTA.
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Folding of SIIIA. Recombinant SIIIA was folded in 0.1 M Tris buffer,
pH 7.5, using 1mMoxidized glutathione (GSSG) and 0.1mMEDTA. The
folding reaction was allowed to proceed overnight at room temperature
and was quenched by the addition of formic acid to a final concentration
of 8%.
Solid-phase extraction of SIIIA. C18 solid-phase extraction columns
(Supelclean LC-18; Supelco) were used to remove the oxidized peptide
from the other components of the folding and cleavage reactions. The
isolated peptide was then dried and purified by high-performance liquid
chromatography (HPLC) on aWaters 600 chromatograph, equippedwith
a dual-wavelength absorbance detector and a Vydac C18 analytical col-
umn. The HPLC separation was run with a linear gradient from 4.5% to
31.5% aqueous (aq) acetonitrile (0.9% change per minute), maintaining
0.1% trifluoroacetic acid (TFA) throughout. This allowed purification of
the correct folding product; mass was validated by matrix-assisted laser
desorption ionization--time of flight mass spectrometry (MALDI-TOF).
Electrophysiology of mammalian NaV channels. The functional ac-
tivity of recombinant SIIIA was assessed electrophysiologically with Xe-
nopus oocytes expressing NaV1.2, as described before (38). Briefly, the
oocyte was placed in a 30-l recording chamber perfused with ND96 and
two-electrode voltage clamped. A holding potential of80 mVwas used,
and activation of sodium channels was achieved by stepping the potential
to 10 mV for 50 ms every 20 s. Exposure to toxin was performed in a
static bath to conserve peptide, as follows. Prior to toxin application, the
perfusion of the bath was halted, and control responses were recorded.
Peptide (3 l at 10 times the final concentration) was then applied to the
bath, which was stirred for 5 s using a micropipette. Recordings of the
onset of block by the peptide were obtained for about 20 min, after which
the perfusion with ND96 was resumed to remove unbound peptide while
the rate of recovery from block wasmonitored for about 20min. The time
course of the onset of block was fit to a single-exponential function to
obtain the observed rate constant of block, kobs. The rate of recovery from
block during peptide washout was too slow tomeasure by curve fitting, so
koff was estimated from the level of recovery after 20 min of washing and
assuming exponential decay of block (17). All recordings were obtained at
room temperature.
Immunostaining. Fluorescent microscopy analysis was performed as
described previously by Erhardt and Hughes (25).
SUPPLEMENTAL MATERIAL
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